These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24983014)

  • 1. The remote origins of a street drug.
    Aronson SM
    R I Med J (2013); 2014 Jul; 97(7):10. PubMed ID: 24983014
    [No Abstract]   [Full Text] [Related]  

  • 2. [Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
    Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6899. PubMed ID: 10643372
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ecstasy, new psychotropic drugs].
    Djezzar S
    Soins Psychiatr; 2009; (262):35-7. PubMed ID: 19579485
    [No Abstract]   [Full Text] [Related]  

  • 4. Consumption and dangers of ecstasy: an amphetamine derivative with a misleading reputation of safety.
    Prescrire Int; 1999 Dec; 8(44):188-9. PubMed ID: 11503823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Street drug roulette continues.
    Smith M
    Emerg Med Serv; 2002 Jun; 31(6):30. PubMed ID: 12078405
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning].
    Hedetoft C; Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6907-11. PubMed ID: 10643376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs on the street: an introduction.
    Singer M
    J Ethn Subst Abuse; 2005; 4(2):1-7. PubMed ID: 16275632
    [No Abstract]   [Full Text] [Related]  

  • 8. A guide to non-opiate illicit drugs.
    Robson P
    Practitioner; 1996 Mar; 240(1560):140-8. PubMed ID: 8710728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ecstasy and related drugs in biological materials].
    Christophersen AS; Smith-Kielland A
    Tidsskr Nor Laegeforen; 1999 Feb; 119(5):702. PubMed ID: 10095396
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on Vrolijk et al. (2017): The paradox of the quality control problem.
    Barratt MJ; Ritter A
    Addiction; 2017 Jan; 112(1):101-102. PubMed ID: 27936508
    [No Abstract]   [Full Text] [Related]  

  • 11. [Has ecstasy neurotoxic effects in humans?].
    Rosenberg R
    Ugeskr Laeger; 1999 Dec; 161(50):6941. PubMed ID: 10643384
    [No Abstract]   [Full Text] [Related]  

  • 12. Alcohol, ecstasy, Aldous Huxley's 'soma'.
    Parrott AC
    J Psychopharmacol; 2007 Jan; 21(1):8-9. PubMed ID: 17213249
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition to and from injecting drug use among regular ecstasy users.
    Dunn M; Degenhardt L; Bruno R
    Addict Behav; 2010 Oct; 35(10):909-12. PubMed ID: 20587367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical complications derived from lucid drug use].
    Cambronero JA; Nevado E; Trascasa M
    Rev Clin Esp; 2000 Aug; 200(8):432-4. PubMed ID: 11076180
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Ecstasy" (MDMA): pharmacology, toxicology, and treatment of acute intoxication].
    Liechti ME
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1361-6. PubMed ID: 12802747
    [No Abstract]   [Full Text] [Related]  

  • 17. [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
    Thomasius R; Gouzoulis-Mayfrank E; Karus C; Wiedenmann H; Hermle L; Sack PM; Zeichner D; Küstner U; Schindler A; Krüger A; Uhlmann S; Petersen KU; Zapletalova P; Wartberg L; Schütz CG; Schulte-Markwort M; Obrocki J; Heinz A; Schmoldt A;
    Fortschr Neurol Psychiatr; 2004 Dec; 72(12):679-95. PubMed ID: 15580533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased use of amphetamine-type stimulants threatens east Asian countries.
    Ahmad K
    Lancet; 2002 Jun; 359(9321):1927. PubMed ID: 12057566
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A
    Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
    Davis AK; Rosenberg H
    J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.